Estrella Immunopharma (ESLA) Preferred Shares (2023 - 2024)
Estrella Immunopharma (ESLA) posted quarterly Preferred Shares of $500000.0 for Q3 2024, little changed quarter-over-quarter from $500000.0 in Q2 2024.
Estrella Immunopharma (ESLA) Preferred Shares (2023 - 2024) Analysis & Trends
Estrella Immunopharma (ESLA) has reported Preferred Shares for 2 consecutive years, with $500000.0 the latest figure, recorded in Q3 2024.
- In Q3 2024, Preferred Shares changed N/A year-over-year to $500000.0; the TTM figure through Sep 2024 stood at $500000.0 (changed N/A YoY), while the FY2024 annual figure was $500000.0, down 90.0% from the prior year.
- Preferred Shares steadied at $500000.0 in Q3 2024 per ESLA's latest filing, from $500000.0 in the prior quarter.
- Across five years, Preferred Shares topped out at $5.0 million in Q2 2023 and bottomed at $500000.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Estrella Immunopharma | 32.29 Mn | 32.14 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 500,000.00 |
| Jun 30, 2024 | 500,000.00 |
| Mar 31, 2024 | 500,000.00 |
| Dec 31, 2023 | 500,000.00 |
| Jun 30, 2023 | 5.00 Mn |